Indeed, it has been shown that SMARCB1, acting distinctly from the SWI/SNF complex, acts as a tumor suppressor in rhabdoid tumors by promoting Pol II pausing of MYC target genes(30). This evidence concerns the gene SMARCA1 and rhabdoid tumor.